Bell Tiffany K, Ansari Muhammad, Joyce Julie M, Mercier Leah J, Gobbi David G, Frayne Richard, Debert Chantel, Harris Ashley D
From the Department of Radiology (T.K.B., J.M.J., D.G.G., R.F., A.D.H.), University of Calgary, Calgary, Alberta, Canada
Hotchkiss Brain Institute (T.K.B., J.M.J., L.J.M., R.F., C.D., A.D.H.), University of Calgary, Calgary, Alberta, Canada.
AJNR Am J Neuroradiol. 2025 Feb 3;46(2):435-442. doi: 10.3174/ajnr.A8454.
It is estimated that 18%-30% of patients with concussion experience symptoms lasting more than 1 month, known as persistent post-concussion symptoms (PPCS). Symptoms can be debilitating, and include headache, dizziness, nausea, problems with memory and concentration, sleep and mood disruption, and exercise intolerance. Previous studies have used quantitative susceptibility mapping (QSM) to show altered tissue susceptibility levels in adults acutely following concussion, however this finding has yet to be investigated in participants with PPCS.
In this exploratory case-controlled study, we measured tissue susceptibility using QSM in 24 participants with PPCS after mild traumatic brain injury (mTBI) and 23 healthy controls with no history of concussion. We compute tissue susceptibility for 7 white matter tracts and 3 deep gray matter regions and compare tissue susceptibility between groups using ANCOVA models controlling for age and sex. We also assess the relationship between regional tissue susceptibility and symptoms.
There were no significant differences between tissue susceptibility in participants with PPCS compared with control subjects in any of the evaluated regions. However, we show lower tissue susceptibility across 4 white matter tracts was generally associated with worse symptoms in the PPCS group. Specifically, we saw relationships between white matter susceptibility and headache ( = .006), time since injury ( = .03), depressive symptoms ( = .021), and daytime fatigue ( = .01) in participants with PPCS.
These results provide evidence in support of persistent changes in the brain months to years after injury and highlight the need to further understand the pathophysiology of PPCS, to determine effective prevention and treatment options.
据估计,18%-30%的脑震荡患者会出现持续超过1个月的症状,即持续性脑震荡后症状(PPCS)。这些症状可能使人衰弱,包括头痛、头晕、恶心、记忆和注意力问题、睡眠和情绪紊乱以及运动不耐受。先前的研究已使用定量磁化率成像(QSM)显示成年人在脑震荡后急性期组织磁化率水平发生改变,然而这一发现尚未在PPCS患者中进行研究。
在这项探索性病例对照研究中,我们使用QSM测量了24名轻度创伤性脑损伤(mTBI)后患有PPCS的参与者以及23名无脑震荡病史的健康对照者的组织磁化率。我们计算了7个白质束和3个深部灰质区域的组织磁化率,并使用控制年龄和性别的协方差分析模型比较两组之间的组织磁化率。我们还评估了区域组织磁化率与症状之间的关系。
在任何评估区域中,PPCS参与者与对照受试者的组织磁化率之间均无显著差异。然而,我们发现PPCS组中4个白质束的组织磁化率较低通常与更严重的症状相关。具体而言,我们观察到PPCS参与者的白质磁化率与头痛(P = 0.006)、受伤时间(P = 0.03)、抑郁症状(P = 0.021)和日间疲劳(P = 0.01)之间存在关联。
这些结果为损伤后数月至数年大脑的持续变化提供了证据,并强调需要进一步了解PPCS的病理生理学,以确定有效的预防和治疗方案。